[#content_spinnerchief]
Related Posts
African Bundibugyo Ebolavirus Vaccine Candidate To Be Advanced To Clinical Trials
- CoreNews Africa
- September 3, 2026
- 0
CEPI backs Minapharm’s Bundibugyo ebolavirus vaccine candidate, based on ProBioGen’s proprietary MVA-CR19 platform Leading African biopharmaceutical company Minapharm Group, headquartered in Egypt with subsidiaries […]